Brits face new £185 visa fee when visiting the US under new rules
The new fee falls under President Donald Trump's 'One Big Beautiful Bill' and could see Brits paying a substantial fee to visit
Advertisement
3
Brits could have to pay a new fee to visit the US
Credit: Getty
3
Under a new bill, any traveller that needs a 'nonimmigrant visa' will have to pay $250
Credit: Getty
The fee will apply to anyone who needs a 'non-immigrant visa' - which includes people travelling for
business
, study and temporary work for more than three months.
It will cost around $250 (£185.80) and is expected to be introduced before the end of 2025.
The cost will also be on top of all existing visa application fees.
Individuals will pay the fee once a visa is issued and if an application is denied, then you won't be charged the fee.
Advertisement
Read more on travel inspo
The fee will also be reimbursed if
travellers
stick to their visa conditions such as not working illegally and not overstaying their visa by more than five days.
The reimbursement will be given after your visa expires - although, the process is not clear yet.
Once the fee is implemented, the
money
will go to the US treasury Department's general fund and is estimated to bring in $28.9billion (£21.3billion) over the
next
decade.
There will also be an increase in the fee for the I-94 form, which records arrival and departure dates.
Advertisement
Most read in News Travel
Exclusive
The fee will rise from $6 (£4.46) to $24 (£17.84).
According to
immigration
system."
Big Changes Coming to Airport Security: TSA Liquid Rule May Be Axed Soon
However, under the Visa Waiver Programme (VWP) - which the UK is part of - most Brits travelling to the US for tourism or short business trips, do not need a visa.
Instead, they will need to apply for an
Advertisement
As a result, Brits eligible for and using an ESTA, will not need to pay the new Visa Integrity Fee.
Brits that will be impacted by the new fee include those travelling for a purpose not covered by the VWP such as long-term study or certain types of
employment
or those not eligible for VWP due to their travel
history
, like travel to restricted countries.
According to the
Though travellers may be unable to apply for an ESTA visa waiver if they have been arrested, have a criminal record, have been refused admission into or have been deported from the US or have previously overstayed an ESTA visa waiver.
Advertisement
An ESTA application costs $21 (£15.60) and can take up to 72 hours to be approved.
Tourist visa waiver for US holidays to cost more
THE fee for an Electronic System for Travel Authorization (ESTA) is expected to rise in the future.
Thanks to a new bill being passed, the price of an ESTA is set to double from $21 (£15.38) to $40 (£29.30).
Before entering the US, Brits are required to apply for an Electronic System for Travel Authorization (ESTA).
The fee is currently $21 (£15.38) to apply for an ESTA - a price which was introduced in May 2022.
Prior to this date, the fee was $14 (£10.25) and will now rise to $40 (£29.30) although an official start date is yet to be confirmed.
The rise in fees is part of US President Donald Trump's "One Big Beautiful Bill".
The current rules require every visitor from the UK to apply for an ESTA to be allowed access into the United States.
An ESTA is generally valid for two years from the date of approval, or until the passport used for the application expires, whichever comes first.
If your passport expires before the two-year period, your ESTA will be valid only until the passport's expiration date.
These are the latest travel rules for Brits heading to America after European tourists have been stopped at the border.
Plus,
3
However, Brits can avoid the fee under the Visa Waiver Programme
Credit: Getty
Advertisement
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
an hour ago
- Irish Examiner
Hilton hotel group lifts profit forecast as US travel demand recovers
Hotel group Hilton Worldwide lifted its 2025 profit forecast on expectations of a complete recovery in domestic travel demand in the US after a sharp pullback earlier this year. But the company's projection for third-quarter profit came in below analysts' expectations, sending the hotel operator's shares down more than 2% on Wednesday. Some travel companies, including Delta Airlines and United Airlines, recently said US travel demand had steadied after a setback in March driven by President Donald Trump's trade war. "We believe the [US] economy... is set up for better growth over the intermediate term, which should accelerate travel demand and, when paired with low industry supply growth, unlock stronger revenue per available room," said Hilton chief executive Christopher Nassetta. 'On the development side, we achieved the largest pipeline in our history, and we remain confident in our ability to deliver net unit growth between 6% and 7% for the next several years,' he added. International tourists from Canada and Europe have cut down US visits. Hilton's second-quarter US room revenue fell 1.5% compared to a year earlier. However, total revenue for the quarter ended June 30 was $3.14bn (€2.69bn), up 6.3% from a year earlier.. Hilton operates 15 hotels in Ireland including the Montenotte Hotel and the Ballymaloe House Hotel — both of which are in Cork. Bernstein analyst Richard Clarke also raised concerns about the company's ability to meet its 6% to 7% projection for 2025 net unit growth, which refers to the number of rooms added to the company's portfolio. Hilton will need a record second half to meet even the low end of its full-year net unit growth forecast, prompting concerns of a potential downgrade, Mr Clarke said. The company forecast its full-year adjusted profit to be in the range of $7.83 and $8 per share, compared with its earlier forecast of $7.76 to $7.94. The Waldorf Astoria-parent, which last week reopened its flagship hotel in New York after eight years of restoration, posted an adjusted profit of $2.20 per share in the second quarter, beating Wall Street estimates of $2.04, according to data compiled by LSEG. Reuters Read More Davy to focus more investment on European markets amid volatility in US
The Irish Sun
an hour ago
- The Irish Sun
Massive Spanish hotspot introduces 10 new rules for tourists including bikini bans – you can risk a £650 fine
A POPULAR Spanish holiday hotspot has launched a set of new rules for tourists including 'dressing completely'. Those planning a trip to summer should watch out for the new regulations that tourists need to follow. Advertisement 4 Malaga has introduced a set of new tourist rules Credit: Getty 4 In addition to basic rules such as not leaving rubbish, there are some slightly more odd rules Credit: Getty Among the 10 rules launched in Malaga Tourism's 'Improve Your Stay Campaign', holidaymakers must 'dress completely' and 'not be conspicuous'. The set of rules - which initially were introduced last summer - has been updated as part of a behaviour campaign in an attempt to curb The list of 'strongly suggested' rules has been plastered across buses, billboards as well as social media. In a post on social media platform X, Malaga Tourism shared more information about some of the rules. Advertisement Read more on Spain Under the 'do not be conspicuous' rule, the post states: "Do not shout, sing or turn up the volume of your music. "Respect the resting hours of your neighbours , including the elderly, the sick, students, children and essential workers." Under the 'dress completely' rule, the post states: "Both on the street and in public places, always wear an upper garment for respect and hygiene." The post adds that scooters should only be ridden by one person, and cyclists should stick to bike lanes - not the pavement. Advertisement Most read in News Travel In addition, visitors are expected to not litter and use designated bins and toilets. Those who break the rules could be handed a The Spanish region undiscovered by Brits despite seaside views and ancient Roman cities Back in January, it was announced that Malaga was banning the registration of new holiday lets in 43 districts of the city. The ban will be in place for three years, though it could be extended. Advertisement The different areas where the rules apply have all reached or exceeded eight per cent of houses in their region being An additional 32 secondary zones have also been identified where the proportion of New short-term holiday lets will be allowed in these areas until the eight per cent threshold is reached. 4 One rule tells tourists to 'dress completely' Credit: Getty Advertisement Malaga is loved by many Brits for its host of beaches, vibrant live music venues and top dining spots. And what is even better is that the holiday hotspot gets more than 300 days of sun a year. In the city itself, the old town is mainly pedestrianised - making it perfect to explore on foot. The city also has an 11th century forest with Advertisement Holidaying in Spain this summer? The Plus, from sea pools to hidden caves - S 4 The rules follow the city clamping down on the amount of short-term holiday lets available Credit: Getty
Irish Times
an hour ago
- Irish Times
Pharma companies unprepared for production shift amid US tariffs
Just one in seven pharmaceutical companies could shift production to the United States within three months should US tariffs on imported drugs become too onerous, new research from consultancy Sia has found. The research, which is based on interviews carried out in June and July with seven senior executives at leading pharmaceutical firms and contract manufacturers, shows none of the organisations feel fully prepared for the potential disruptions that tariffs could cause. The majority of the organisations surveyed, based between Ireland and the US, said they are still in the early phases of scenario planning and are hesitant to commit to major changes while trade negotiations remain unresolved. The US government is reportedly considering tariffs of up to 200 per cent on pharmaceutical products from the EU, China and India – a move that could reshape global drug supply chains and significantly increase costs. [ Donald Trump says pharmaceutical tariffs could reach 200 per cent Opens in new window ] The research found the proposed tariffs would likely result in immediate cost increases, potential drug shortages and long-term consequences for innovation. Higher operational costs 'may reduce investment' in research and development, 'slow the delivery' of new treatments and 'force price increases' that would ultimately affect consumers, according to the findings. Ireland's role as a strategic export hub is also emphasised in the research. In May alone, the value of pharmaceutical and medicinal product exports from Ireland rose by nearly three-quarters to €13.7 billion compared to the same month last year. The research also shows growing momentum behind US-based manufacturing. More than $170 billion in investment has been announced or redirected toward domestic pharmaceutical capacity over the next five years, with 57 per cent of organisations planning to increase their US footprint. 'This shift reflects a broader trend toward regionalisation of supply chains and reduced reliance on geopolitically sensitive markets,' according to the report. Research from 2022 showed US pharma manufacturing facilities were operating at around 50 per cent capacity. Contract development and manufacturing organisations are operating around 55 per cent capacity, suggesting a 'near-term opportunity for expansion without the need for major infrastructure spend'. Meanwhile, staffing and talent development 'still present potential challenges'. However, 'challenges remain' in terms of workforce availability and production agility. The complexity and regulatory requirements of pharmaceutical production mean that relocating manufacturing operations is a 'slow and resource-intensive process'. With US patients already paying more than $12,000 per year on average for healthcare – the highest rate globally – the industry is bracing for additional economic pressure. Niall Cunneen, associate partner Ireland and Britain at Sia, said the pharmaceutical industry has 'long benefited' from highly optimised global supply chains, but the research shows 'these very strengths have become vulnerabilities' in the face of rapidly shifting trade policy. 'The potential Trump tariffs represent a genuine stress test – not just of operational flexibility, but of long-term strategic resilience,' he said. Mr Cunneen said many pharma companies are still waiting for regulatory clarity before making major decisions. 'That hesitation is understandable, but risky,' he said. 'In today's environment, waiting too long to act could mean losing access, margin or momentum.' 'What we're seeing is a growing pivot toward domestic investment, with more than $170 billion of US-based capacity already committed over the next five years.
